Skip to main content
. Author manuscript; available in PMC: 2016 Apr 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):554–561. doi: 10.1097/QAI.0000000000000510

Table 1.

Baseline characteristics by arm

N (%) or median (IQR)
LT-MAT
(N = 623)
ST-MAT
(N = 627)
Demographic characteristics
Age 33 (27,39) 34 (28,39)
Male 574 (92%) 577 (92%)
Ethnic minority1 262 (42%) 260 (41%)
Married/Living with Partner 321 (51%) 327 (52%)
Days employed (prior 30 days) 15 (0,28) 16 (0,27)
Injection drug use behaviors
Used needle/syringe after someone in the prior 6 months 136 (22%) 121 (19%)
Age at first injection 24 (21, 30) 25 (20, 31)
Years of injection 7 (3, 12) 7 (3, 12)
Self-reported drugs injected (prior 30 days)
 Heroin 556 (90%) 556 (89%)
 Opium 66 (11%) 69 (11%)
 Amphetamine 0 (0%) 0 (0%)
 Methadone 3 (1%) 0 (0%)
 Benzodiazepine 5 (1%) 10 (2%)
Median number of injections (prior 30 days) 84 (60, 90) 84 (60, 90)
Urine drug screen
 Opioid 623 (100%) 627 (100%)
 Amphetamine 8 (1%) 12 (2%)
 Methadone 25 (4%) 18 (3%)
 Benzodiazepine 111 (18%) 124 (20%)
1

Ethnic minority are participants who did not identify as Han in China or Thai in Thailand